Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2

被引：32

作者：

Kennerson, ML ^{[1
]}

Zhu, D

Gardner, RJM

Storey, E

Merory, J

Robertson, SP

Nicholson, GA

机构：

[1] Univ Sydney, Neurobiol Lab, ANZAC Res Inst, Concord Hosp, Sydney, NSW 2139, Australia

[2] Concord Hosp, Mol Med Lab, Concord, NSW, Australia

[3] Monash Univ, Genet Hlth Serv Victoria, Royal Childrens Hosp, Melbourne, Vic, Australia

[4] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia

[5] Austin & Repatriat Hosp, Melbourne, Vic, Australia

来源：

AMERICAN JOURNAL OF HUMAN GENETICS | 2001年 / 69卷 / 04期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1086/323743

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The hereditary disorders of peripheral nerve form one of the most common groups of human genetic diseases, collectively called Charcot-Marie-Tooth (CMT) neuropathy. Using linkage analysis we have identified a new locus for a form of CMT that we have called "(d) under bar ominant intermediate CMT" (DI-CMT). A genomewide screen using 383 microsatellite markers showed strong linkage to the short arm of chromosome 19 (maximum LOD score 4.3, with a recombination fraction (theta) of 0, at D19S221 and maximum LOD score 5.28, theta =0, at D19S226). Haplotype analysis performed with 14 additional markers placed the D1-CMT locus within a 16.8-cM region flanked by the markers D19S586 and D19S546. Multipoint linkage analysis suggested the most likely location at D19S226 (maximum multipoint LOD score 6.77), within a 10-cM confidence interval. This study establishes the presence of a locus for DI-CMT on chromosome 19p12-p13.2.

引用

页码：883 / 888

页数：6

共 41 条

[1] CONNEXIN MUTATIONS IN X-LINKED CHARCOT-MARIE-TOOTH DISEASE
BERGOFFEN, J
SCHERER, SS
WANG, S
SCOTT, MO
BONE, LJ
PAUL, DL
CHEN, K
LENSCH, MW
CHANCE, PF
FISCHBECK, KH
[J]. SCIENCE, 1993, 262 (5142) : 2039 - 2042
[2] Bodzioch M, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<72::AID-HUMU10>3.0.CO
[3] 2-X
[4] Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2
Bolino, A
Muglia, M
Conforti, FL
LeGuern, E
Salih, MAM
Georgiou, DM
Christodoulou, K
Hausmanowa-Petrusewicz, I
Mandich, P
Schenone, A
Gambardella, A
Bono, F
Quattrone, A
Devoto, M
Monaco, AP
[J]. NATURE GENETICS, 2000, 25 (01) : 17 - 19
[5] REPORT OF THE COMMITTEE ON METHODS OF LINKAGE ANALYSIS AND REPORTING
CONNEALLY, PM
EDWARDS, JH
KIDD, KK
LALOUEL, JM
MORTON, NE
OTT, J
WHITE, R
[J]. CYTOGENETICS AND CELL GENETICS, 1985, 40 (1-4): : 356 - 359
[6] COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
[7] DAVIS CJF, 1978, J GENET HUM, V26, P311
[8] The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype
De Jonghe, P
Timmerman, V
Ceuterick, C
Nelis, E
De Vriendt, E
Löfgren, A
Vercruyssen, A
Verellen, C
Van Maldergem, L
Martin, JJ
Van Broeckhoven, C
[J]. BRAIN, 1999, 122 : 281 - 290
[9] LOWER MOTOR AND PRIMARY SENSORY NEURON DISEASES WITH PERONEAL MUSCULAR ATROPHY .2. NEUROLOGIC GENETIC AND ELECTROPHYSIOLOGIC FINDINGS IN VARIOUS NEURONAL DEGENERATIONS
DYCK, PJ
LAMBERT, EH
[J]. ARCHIVES OF NEUROLOGY, 1968, 18 (06) : 619 - &
[10] BSMAP, a novel protein expressed specifically in the brain whose gene is localized on chromosome 19p12
Elson, GCA
de Coignac, AB
Aubry, JP
Delneste, Y
Magistrelli, G
Holzwarth, J
Bonnefoy, JY
Gauchat, JF
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (01) : 55 - 62

← 1 2 3 4 5 →